Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS · Delayed Price · Currency is USD
0.0675
+0.0041 (6.47%)
Aug 18, 2025, 9:30 AM EDT
Rafarma Pharmaceuticals Market Cap
Rafarma Pharmaceuticals has a market cap or net worth of $5.56 million as of August 18, 2025. Its market cap has decreased by -47.17% in one year.
Market Cap
5.56M
Enterprise Value
n/a
Revenue
133.33K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 18, 2012, Rafarma Pharmaceuticals's market cap has decreased from 20.34M to 5.56M, a decrease of -72.65%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 5.56M | -17.93% |
| Dec 31, 2024 | 6.78M | -70.44% |
| Dec 29, 2023 | 22.93M | -40.44% |
| Dec 30, 2022 | 38.51M | -47.44% |
| Dec 31, 2021 | 73.26M | -47.17% |
| Dec 31, 2020 | 138.67M | 273.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |